UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 428

Sortiert nach

Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics

Journal of the American College of Cardiology, 2019-04, Vol.73 (15), p.1931-1944

2019

Volltextzugriff (PDF)

The pharmacokinetics and pharmacodynamics of SGLT2 inhibitors for type 2 diabetes mellitus: the latest developments

Expert opinion on drug metabolism & toxicology, 2018-12, Vol.14 (12), p.1287-1302

2018

Volltextzugriff (PDF)

Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction

Circulation. Cardiovascular imaging, 2023-04, Vol.16 (4), p.e015298-e015298

2023

Volltextzugriff (PDF)

Metabolism of the failing heart and the impact of SGLT2 inhibitors

Expert opinion on drug metabolism & toxicology, 2019-04, Vol.15 (4), p.275-285

2019

Volltextzugriff (PDF)

Beginning to Understand High-Density Lipoproteins

Endocrinology and metabolism clinics of North America, 2014-12, Vol.43 (4), p.913-947

2014

Volltextzugriff (PDF)

Inhibition of Sodium Glucose Cotransporters Improves Cardiac Performance

International journal of molecular sciences, 2019-07, Vol.20 (13), p.3289

2019

Volltextzugriff (PDF)

Renal and Cardiovascular Metabolic Impact Caused by Ketogenesis of the SGLT2 Inhibitors

International journal of molecular sciences, 2023-02, Vol.24 (4), p.4144

2023

Volltextzugriff (PDF)

Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease

Journal of cardiovascular development and disease, 2022-12, Vol.9 (12), p.437

2022

Volltextzugriff (PDF)

The anti-inflammatory effects of SGLT inhibitors

Aging (Albany, NY.), 2019-08, Vol.11 (16), p.5866-5867

2019

Volltextzugriff (PDF)

Cardiac Complications After Community-Acquired Pneumonia

The American journal of cardiology, 2016-01, Vol.117 (2), p.310-310

2016

Volltextzugriff (PDF)

Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamber

Thrombosis and haemostasis, 2007-10, Vol.98 (4), p.883

2007

Volltextzugriff (PDF)

Accelerated reendothelialization, increased neovascularization and erythrocyte extravasation after arterial injury in BAMBI-/- mice

PloS one, 2013-03, Vol.8 (3), p.e58550-e58550

2013

Volltextzugriff (PDF)

Diesel exhaust inhalation increases thrombus formation in man

European heart journal, 2008-12, Vol.29 (24), p.3043-3051

2008

Volltextzugriff (PDF)

Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC State-of-the-Art Review

Journal of the American College of Cardiology, 2021-04, Vol.77 (13), p.1660-1669

2021

Volltextzugriff (PDF)

Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression

European heart journal, 2010-07, Vol.31 (13), p.1573-1582

2010

Volltextzugriff (PDF)

The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion

International journal of cardiology, 2011-03, Vol.147 (3), p.428-432

2011

Volltextzugriff (PDF)

Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging

Circulation (New York, N.Y.), 2000-08, Vol.102 (5), p.506-510

2000

Volltextzugriff (PDF)

Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction

Journal of the American College of Cardiology, 2021-01, Vol.77 (3), p.243-255

2021

Volltextzugriff (PDF)

Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences

Annals of internal medicine, 2001-02, Vol.134 (3), p.224

2001

Volltextzugriff (PDF)

Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study

JACC. Cardiovascular imaging, 2021-02, Vol.14 (2), p.393-407

2021

Volltextzugriff (PDF)

Membrane-associated CD40L and sCD40L in atherothrombotic disease

Thrombosis and haemostasis, 2003-09, Vol.90 (3), p.377

2003

Volltextzugriff (PDF)

New approaches to triglyceride reduction: Is there any hope left?

American journal of preventive cardiology, 2024-06, Vol.18, p.100648-100648, Article 100648

2024

Volltextzugriff (PDF)

The Sum of Two Evils

Journal of the American College of Cardiology, 2014-11, Vol.64 (18), p.1926-1928

2014

Volltextzugriff (PDF)

Spark That Lights the Fire: Infection Triggers Cardiovascular Events

Journal of the American Heart Association, 2018-11, Vol.7 (22), p.e011175-e011175

2018

Volltextzugriff (PDF)

Meet the Editorial Board Member

Current cardiology reviews, 2021-11, Vol.17 (6), p.1

Badimon, Juan J.

2021

Volltextzugriff (PDF)

1 – 25 von 428

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(403)
Mit Volltextzugriff
(369)

Publikationsform

Artikel
(425)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(267)
Life Sciences & Biomedicine
(262)
Cardiovascular System & Cardiology
(208)
Humans
(195)
Cardiac & Cardiovascular Systems
(162)
Biological And Medical Sciences
(142)
Medical Sciences
(140)
Animals
(129)
Peripheral Vascular Disease
(106)
Atherosclerosis
(97)
Male
(91)
Cardiology. Vascular System
(73)
Female
(65)
Blood And Lymphatic Vessels
(50)
Hematology
(50)
Swine
(49)
Thrombosis
(47)
Middle Aged
(43)
Pharmacology. Drug Treatments
(41)
Cardiology
(36)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics

The pharmacokinetics and pharmacodynamics of SGLT2 inhibitors for type 2 diabetes mellitus: the latest developments

Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction

Metabolism of the failing heart and the impact of SGLT2 inhibitors

Beginning to Understand High-Density Lipoproteins

Inhibition of Sodium Glucose Cotransporters Improves Cardiac Performance

Renal and Cardiovascular Metabolic Impact Caused by Ketogenesis of the SGLT2 Inhibitors

Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease

The anti-inflammatory effects of SGLT inhibitors

Cardiac Complications After Community-Acquired Pneumonia

Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamber

Accelerated reendothelialization, increased neovascularization and erythrocyte extravasation after arterial injury in BAMBI-/- mice

Diesel exhaust inhalation increases thrombus formation in man

Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC State-of-the-Art Review

Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression

The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion

Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging

Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction

Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences

Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study

Membrane-associated CD40L and sCD40L in atherothrombotic disease

New approaches to triglyceride reduction: Is there any hope left?

The Sum of Two Evils

Spark That Lights the Fire: Infection Triggers Cardiovascular Events

Meet the Editorial Board Member

Suchergebnisse filtern